KEPPRA(LEVETIRACETAM) 250MG
39,600.00Fr
Keppra is indicated as monotherapy in treating partial-onset seizures with or without secondary generalization in adults and adolescents from 16 years of age with newly diagnosed epilepsy.
No more offers for this product!
General Inquiries
There are no inquiries yet.
